A company being built from the ashes of IBM’s Watson Health division is launching new lines of business with a much different message: The real value is in the health data, not the fancy AI engine it might eventually power.
The new venture, dubbed Merative, will focus on distributing data through channels designed to maximize its value for health plans, providers, pharmaceutical companies, employers and other businesses.
“AI is something that we’ll continue to watch, but you will not see us investing directly to build major AI models and modules,” the company’s CEO, Gerry McCarthy, told STAT, adding that he is hoping to get “back to the basics” of selling access to data and insights drawn from some the industry’s biggest sources of patient information.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect